> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Orphan Status for DynPort Plague Vaccine
- URL: https://www.fdaweb.com/orphan-status-for-dynport-plague-vaccine/
- Published: 2017-03-08T12:00:00.000Z
- Updated: 2026-09-14T22:10:25.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5138160

FDA has granted DynPort Vaccine Co. an orphan drug designation for a plague vaccine being developed on behalf of the Defense Department. The recombinant rF1V product is intended to be used for pre-exposure prophylaxis to combat infection with *Yersinia pestis*, the causative agent of plague. The vaccine is being developed as part of the government’s medical countermeasures portfolio against bioterrorism agents.